(Q56485662)

English

A tribute to Akira Endo, discoverer of a “Penicillin” for cholesterol

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

A tribute to Akira Endo, discoverer of a “Penicillin” for cholesterol (English)

0 references

2

Joseph L. Goldstein

0 references

author name string

Michael S. Brown

series ordinal

1

0 references

publication date

October 2004

0 references

published in

Atherosclerosis. Supplements

0 references

volume

5

0 references

issue

3

0 references

page(s)

13-16

0 references

cites work

Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Tissue sites of degradation of low density lipoprotein: Application of a method for determining the fate of plasma proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Regulation of the activity of the low density lipoprotein receptor in human fibroblasts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Lowering Plasma Cholesterol by Raising LDL Receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Low Density Lipoprotein Receptors in Bovine Adrenal Cortex. II. Low Density Lipoprotein Binding to Membranes Prepared from Fresh Tissue*

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Therapeutic effects of ML-236B in primary hypercholesterolemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

Identifiers

DOI

10.1016/J.ATHEROSCLEROSISSUP.2004.08.007

0 references

ResearchGate publication ID

246590929

0 references

(Q56485662)

A tribute to Akira Endo, discoverer of a “Penicillin” for cholesterol

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)